JP2012532093A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532093A5 JP2012532093A5 JP2012516867A JP2012516867A JP2012532093A5 JP 2012532093 A5 JP2012532093 A5 JP 2012532093A5 JP 2012516867 A JP2012516867 A JP 2012516867A JP 2012516867 A JP2012516867 A JP 2012516867A JP 2012532093 A5 JP2012532093 A5 JP 2012532093A5
- Authority
- JP
- Japan
- Prior art keywords
- cbd
- therapeutic agent
- present
- agent according
- thcv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 11
- 229940124597 therapeutic agent Drugs 0.000 claims 10
- 206010010904 Convulsion Diseases 0.000 claims 7
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 claims 5
- ZROLHBHDLIHEMS-UHFFFAOYSA-N Delta9 tetrahydrocannabivarin Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCC)=CC(O)=C3C21 ZROLHBHDLIHEMS-UHFFFAOYSA-N 0.000 claims 5
- 239000000419 plant extract Substances 0.000 claims 5
- 206010061334 Partial seizures Diseases 0.000 claims 3
- 229930003827 cannabinoid Natural products 0.000 claims 3
- 239000003557 cannabinoid Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 208000028325 tonic-clonic seizure Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0911580.9 | 2009-07-03 | ||
| GB0911580A GB2471523A (en) | 2009-07-03 | 2009-07-03 | Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy |
| PCT/GB2010/051066 WO2011001169A1 (en) | 2009-07-03 | 2010-06-29 | Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016050485A Division JP2016166205A (ja) | 2009-07-03 | 2016-03-15 | てんかんの治療におけるフィトカンナビノイドの１つ又は組合せの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532093A JP2012532093A (ja) | 2012-12-13 |
| JP2012532093A5 true JP2012532093A5 (enExample) | 2013-08-08 |
| JP5904938B2 JP5904938B2 (ja) | 2016-04-20 |
Family
ID=41008705
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012516867A Active JP5904938B2 (ja) | 2009-07-03 | 2010-06-29 | てんかんの治療におけるフィトカンナビノイドの１つ又は組合せの使用 |
| JP2016050485A Pending JP2016166205A (ja) | 2009-07-03 | 2016-03-15 | てんかんの治療におけるフィトカンナビノイドの１つ又は組合せの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016050485A Pending JP2016166205A (ja) | 2009-07-03 | 2016-03-15 | てんかんの治療におけるフィトカンナビノイドの１つ又は組合せの使用 |
Country Status (28)
| Country | Link |
|---|---|
| US (4) | US9066920B2 (enExample) |
| EP (3) | EP2727626A1 (enExample) |
| JP (2) | JP5904938B2 (enExample) |
| KR (1) | KR101727000B1 (enExample) |
| CN (2) | CN102596322A (enExample) |
| AR (1) | AR077448A1 (enExample) |
| AU (1) | AU2010267775C1 (enExample) |
| BR (1) | BR112012000076A2 (enExample) |
| CA (2) | CA3040410C (enExample) |
| CY (1) | CY1115338T1 (enExample) |
| DK (1) | DK2448637T4 (enExample) |
| ES (1) | ES2460623T5 (enExample) |
| GB (3) | GB2471523A (enExample) |
| HR (1) | HRP20140398T4 (enExample) |
| IL (1) | IL217280B (enExample) |
| IN (1) | IN2012DN00804A (enExample) |
| MX (1) | MX2012000257A (enExample) |
| MY (1) | MY156759A (enExample) |
| NZ (2) | NZ597704A (enExample) |
| PL (1) | PL2448637T5 (enExample) |
| PT (1) | PT2448637E (enExample) |
| RU (1) | RU2563143C2 (enExample) |
| SG (1) | SG176914A1 (enExample) |
| SI (1) | SI2448637T2 (enExample) |
| TW (1) | TWI461191B (enExample) |
| UA (1) | UA108852C2 (enExample) |
| WO (1) | WO2011001169A1 (enExample) |
| ZA (1) | ZA201200373B (enExample) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2377218A (en) * | 2001-05-04 | 2003-01-08 | Gw Pharmaceuticals Ltd | Process and apparatus for extraction of active substances and enriched extracts from natural products |
| GB0425248D0 (en) | 2004-11-16 | 2004-12-15 | Gw Pharma Ltd | New use for cannabinoid |
| EP1811983B1 (en) * | 2004-11-16 | 2020-10-07 | GW Pharma Limited | New use for cannabinoid |
| US11062795B2 (en) | 2007-03-02 | 2021-07-13 | Enigami Systems, Inc. | Healthcare data system |
| GB2471523A (en) | 2009-07-03 | 2011-01-05 | Gw Pharma Ltd | Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| GB2479153B (en) * | 2010-03-30 | 2014-03-19 | Gw Pharma Ltd | The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| GB2514054A (en) * | 2011-09-29 | 2014-11-12 | Gw Pharma Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| US11911361B2 (en) | 2014-05-29 | 2024-02-27 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
| US10319475B1 (en) | 2014-06-13 | 2019-06-11 | Enigami Systems, Inc. | Method and apparatus for determining relationships between medications and symptoms |
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2527599A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
| WO2016044370A1 (en) | 2014-09-16 | 2016-03-24 | India Globalization Capital, Inc. | Cannabinoid composition and method for treating pain |
| GB2531278A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| WO2016118391A1 (en) | 2015-01-25 | 2016-07-28 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
| US10238745B2 (en) | 2015-01-31 | 2019-03-26 | Constance Therapeutics, Inc. | Cannabinoid composition and products including α-tocopherol |
| AU2016211314A1 (en) | 2015-01-31 | 2017-08-17 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
| WO2016160542A1 (en) * | 2015-04-01 | 2016-10-06 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
| WO2016176279A1 (en) * | 2015-04-28 | 2016-11-03 | The Regents Of The University Of California | Uses of cannabidiol for treatment of infantile spasms |
| GB2539472A (en) * | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
| GB2541191A (en) * | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| WO2017027651A1 (en) | 2015-08-12 | 2017-02-16 | India Globalization Capital, Inc. | Method and composition for treating cachexia and eating disorders |
| US10806707B2 (en) | 2015-11-24 | 2020-10-20 | Constance Therapeutics, Inc. | Cannabis oil compositions and methods for preparation thereof |
| GB2548873B (en) | 2016-03-31 | 2020-12-02 | Gw Res Ltd | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome |
| US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
| CA3027862A1 (en) | 2016-06-15 | 2017-12-21 | India Globalization Capital, Inc. | Method and composition for treating seizure disorders |
| US10143706B2 (en) | 2016-06-29 | 2018-12-04 | Cannscience Innovations, Inc. | Decarboxylated cannabis resins, uses thereof and methods of making same |
| GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2553139A (en) | 2016-08-25 | 2018-02-28 | Gw Res Ltd | Use of cannabinoids in the treatment of multiple myeloma |
| GB2557921A (en) | 2016-12-16 | 2018-07-04 | Gw Res Ltd | Use of cannabinoids in the treatment of angelman syndrome |
| CN108236608B (zh) * | 2016-12-27 | 2020-05-08 | 汉义生物科技（北京）有限公司 | 大麻二酚与氨己烯酸的药物组合物及其用途 |
| CN108245499B (zh) * | 2016-12-29 | 2020-11-20 | 汉义生物科技（北京）有限公司 | 大麻二酚与双链脂肪酸类抗癫痫药物的组合物及其用途 |
| CN108245510B (zh) * | 2016-12-29 | 2020-11-20 | 汉义生物科技（北京）有限公司 | 大麻二酚与乙丙酰脲类抗癫痫药物的组合物及其用途 |
| CN108245517B (zh) * | 2016-12-29 | 2020-05-08 | 汉义生物科技（北京）有限公司 | 大麻二酚与拉莫三嗪的药物组合物及其用途 |
| GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2560019A (en) | 2017-02-27 | 2018-08-29 | Gw Res Ltd | Use of cannabinoids in the treatment of leukaemia |
| CN108785298A (zh) * | 2017-04-27 | 2018-11-13 | 汉义生物科技（北京）有限公司 | 一种用于治疗癫痫的药物组合物、其制备方法及用途 |
| US20180352848A1 (en) * | 2017-06-07 | 2018-12-13 | NC3 Systems | Smokable cannabis-based product with reduced psychoactive effects |
| GB2564383B (en) | 2017-06-23 | 2021-04-21 | Gw Res Ltd | Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2569961B (en) | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
| GB201806953D0 (en) | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
| GB2583526A (en) | 2019-05-03 | 2020-11-04 | Gw Res Ltd | Use of cannabidiol in the treatment of tuberous sclerosis complex |
| CN110101804A (zh) * | 2019-05-30 | 2019-08-09 | 厦门梓素生物科技有限公司 | 一种含大麻二酚提取物的癫痫药物组合及其制备方法 |
| US20210077421A1 (en) * | 2019-09-17 | 2021-03-18 | Zynerba Pharmaceuticals, Inc. | Treatment of syngap1 encephalopathy |
| GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| EP3912485A1 (en) | 2020-05-18 | 2021-11-24 | Del-Vis Sp. z o.o. | Cigarette product and a method for manufacturing the product |
| WO2022017936A1 (en) * | 2020-07-20 | 2022-01-27 | GW Research Limited | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain |
| GB2597279A (en) * | 2020-07-20 | 2022-01-26 | Gw Res Ltd | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain |
| CA3187303A1 (en) | 2020-07-28 | 2022-02-03 | Impello Biosciences, Inc. | Methods and compositions for altering secondary metabolites in plants |
| US11160757B1 (en) | 2020-10-12 | 2021-11-02 | GW Research Limited | pH dependent release coated microparticle cannabinoid formulations |
| GB2604132A (en) | 2021-02-25 | 2022-08-31 | Gw Res Ltd | Use of cannabidiol and clobazam in the treatment of childhood-onset epilepsy syndromes |
| US11337934B1 (en) | 2021-04-08 | 2022-05-24 | Lanny Leo Johnson | Compositions including a cannabinoid and protocatechuic acid |
| CN118510544A (zh) | 2021-07-29 | 2024-08-16 | 爱莫里大学 | 大麻素类的磷酸酯前药 |
| CA3248533A1 (en) | 2022-04-12 | 2023-10-19 | Shackelford Pharma Inc | TREATMENT OF EPILEPTIC DISORDERS |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6949582B1 (en) | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
| DE10051427C1 (de) * | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
| JP4467883B2 (ja) | 2001-02-14 | 2010-05-26 | ジーダブリュー・ファーマ・リミテッド | 医薬製剤 |
| GB2381450B (en) * | 2001-10-31 | 2006-05-31 | Gw Pharma Ltd | Compositions for administration of natural or synthetic cannabinoids by vaporisation |
| GB0202385D0 (en) | 2002-02-01 | 2002-03-20 | Gw Pharma Ltd | Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions |
| ITPD20020138A1 (it) | 2002-05-24 | 2003-11-24 | Matteo Bevilacqua | Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima. |
| DE10226494A1 (de) | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
| CA2823474A1 (en) | 2002-08-14 | 2004-02-14 | Gw Pharma Limited | Botanical drug substances comprising various proportions of thc and cbd |
| AU2003253005B2 (en) * | 2002-08-14 | 2009-03-19 | Jazz Pharmaceuticals Research Uk Limited | Cannabinoid liquid formulations for mucosal administration |
| EP1811983B1 (en) * | 2004-11-16 | 2020-10-07 | GW Pharma Limited | New use for cannabinoid |
| GB0425248D0 (en) * | 2004-11-16 | 2004-12-15 | Gw Pharma Ltd | New use for cannabinoid |
| TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
| GB2434312B (en) | 2006-01-18 | 2011-06-29 | Gw Pharma Ltd | Cannabinoid-containing plant extracts as neuroprotective agents |
| WO2007142957A2 (en) | 2006-05-30 | 2007-12-13 | Air Systems | Gear drive damper |
| GB2438682A (en) | 2006-06-01 | 2007-12-05 | Gw Pharma Ltd | New use for cannabinoids |
| GB2439393B (en) * | 2006-06-23 | 2011-05-11 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
| GB2449691A (en) | 2007-05-31 | 2008-12-03 | Gw Pharma Ltd | A reference plant lacking medicinal active compound expression |
| GB2450753B (en) * | 2007-07-06 | 2012-07-18 | Gw Pharma Ltd | New Pharmaceutical formulation |
| GB2456183A (en) | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
| GB2459637B (en) | 2008-01-21 | 2012-06-06 | Gw Pharma Ltd | New use for cannabinoids |
| PT2280687T (pt) | 2008-03-26 | 2019-06-04 | Stichting Sanammad | Composições de goma de mascar compreendendo canabinóides |
| GB2478072B (en) | 2008-06-04 | 2012-12-26 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2478074B (en) | 2008-06-04 | 2012-12-26 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2471523A (en) | 2009-07-03 | 2011-01-05 | Gw Pharma Ltd | Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| GB2479153B (en) | 2010-03-30 | 2014-03-19 | Gw Pharma Ltd | The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy |
| US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| GB201111261D0 (en) | 2011-07-01 | 2011-08-17 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders |
| CA2847235C (en) | 2011-08-26 | 2020-07-07 | Bial - Portela & Ca, S.A. | Treatments involving eslicarbazepine acetate or eslicarbazepine |
| GB2514054A (en) | 2011-09-29 | 2014-11-12 | Gw Pharma Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| GB2496687A (en) | 2011-11-21 | 2013-05-22 | Gw Pharma Ltd | Tetrahydrocannabivarin (THCV) in the protection of pancreatic islet cells |
| US20150181924A1 (en) | 2013-10-31 | 2015-07-02 | Michael R. Llamas | Cannabidiol liquid composition for smoking |
| US10052339B2 (en) | 2014-03-21 | 2018-08-21 | Bodybio Inc. | Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids |
| CA2950424C (en) | 2014-05-29 | 2023-03-14 | Insys Pharma, Inc. | Stable cannabinoid formulations |
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
-
2009
- 2009-07-03 GB GB0911580A patent/GB2471523A/en not_active Withdrawn
-
2010
- 2010-06-29 GB GB1121919.3A patent/GB2485291B/en not_active Expired - Fee Related
- 2010-06-29 SG SG2011094042A patent/SG176914A1/en unknown
- 2010-06-29 PL PL10734541.5T patent/PL2448637T5/pl unknown
- 2010-06-29 KR KR1020127003123A patent/KR101727000B1/ko active Active
- 2010-06-29 NZ NZ597704A patent/NZ597704A/en unknown
- 2010-06-29 SI SI201030622T patent/SI2448637T2/sl unknown
- 2010-06-29 JP JP2012516867A patent/JP5904938B2/ja active Active
- 2010-06-29 UA UAA201201092A patent/UA108852C2/ru unknown
- 2010-06-29 CA CA3040410A patent/CA3040410C/en active Active
- 2010-06-29 EP EP14153495.8A patent/EP2727626A1/en not_active Withdrawn
- 2010-06-29 CA CA2766082A patent/CA2766082C/en active Active
- 2010-06-29 GB GB1010897.5A patent/GB2471565B/en active Active
- 2010-06-29 IN IN804DEN2012 patent/IN2012DN00804A/en unknown
- 2010-06-29 DK DK10734541.5T patent/DK2448637T4/da active
- 2010-06-29 AU AU2010267775A patent/AU2010267775C1/en active Active
- 2010-06-29 EP EP10734541.5A patent/EP2448637B2/en active Active
- 2010-06-29 WO PCT/GB2010/051066 patent/WO2011001169A1/en not_active Ceased
- 2010-06-29 MX MX2012000257A patent/MX2012000257A/es active IP Right Grant
- 2010-06-29 MY MYPI2011006198A patent/MY156759A/en unknown
- 2010-06-29 ES ES10734541T patent/ES2460623T5/es active Active
- 2010-06-29 US US13/380,305 patent/US9066920B2/en active Active
- 2010-06-29 NZ NZ620838A patent/NZ620838A/en unknown
- 2010-06-29 CN CN2010800310652A patent/CN102596322A/zh active Pending
- 2010-06-29 EP EP20175934.7A patent/EP3718603A1/en active Pending
- 2010-06-29 HR HRP20140398TT patent/HRP20140398T4/hr unknown
- 2010-06-29 BR BR112012000076-4A patent/BR112012000076A2/pt not_active Application Discontinuation
- 2010-06-29 RU RU2012103603/15A patent/RU2563143C2/ru active
- 2010-06-29 CN CN201610808754.9A patent/CN106236744A/zh active Pending
- 2010-06-29 PT PT107345415T patent/PT2448637E/pt unknown
- 2010-07-02 TW TW099121811A patent/TWI461191B/zh not_active IP Right Cessation
- 2010-07-02 AR ARP100102377A patent/AR077448A1/es unknown
-
2011
- 2011-12-29 IL IL217280A patent/IL217280B/en active IP Right Grant
-
2012
- 2012-01-17 ZA ZA2012/00373A patent/ZA201200373B/en unknown
-
2014
- 2014-05-12 CY CY20141100335T patent/CY1115338T1/el unknown
- 2014-12-22 US US14/579,061 patent/US9522123B2/en active Active
-
2016
- 2016-03-15 JP JP2016050485A patent/JP2016166205A/ja active Pending
- 2016-11-09 US US15/346,844 patent/US20170273913A1/en not_active Abandoned
-
2018
- 2018-10-02 US US16/149,983 patent/US20190247324A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532093A5 (enExample) | ||
| RU2012103603A (ru) | Применение одного или комбинации фитоканнабиноидов для лечения эпилепсии | |
| MA38276A1 (fr) | Dérivés de l'exendine 4 pour l’utilisation dans le traitement des troubles du syndrome metabolique, y compris le diabete et l'obesite, ainsi que la reduction de l'apport alimentaire excessif. | |
| CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
| CR11723A (es) | Agente para tratar enfermedad | |
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| ECSP12012125A (es) | Ariltriazolonas ligadas a bisarilo y su uso | |
| WO2011113013A3 (en) | Methods and compositions for treating viral or virally-induced conditions | |
| BR112014024793A2 (pt) | método de inibição da ativação do complemento dependente de masp-3, e, composição farmacêutica. | |
| AR084932A1 (es) | Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica | |
| CL2013001136A1 (es) | Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional. | |
| CL2013000677A1 (es) | Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn. | |
| MX2011011596A (es) | Perifosina y capecitabina como un tratamiento combinado para cancer. | |
| MY172040A (en) | Synergistic dietary supplement for enhancing physical performance | |
| MY160377A (en) | Topical pharmaceutical compositions | |
| PH12013500371A1 (en) | Therapeutic agent for pain | |
| EP2575456A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS | |
| JP2011504921A5 (enExample) | ||
| JP2015500340A5 (enExample) | ||
| RU2016127361A (ru) | Гастроретентивные фармацевтические композиции для перорального введения | |
| WO2015004634A3 (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
| WO2011151786A3 (en) | Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer | |
| ZA201008022B (en) | Pharmaceutical compositions for the treatment of warts | |
| AR076016A1 (es) | Domperidona a una dosis diaria baja para su uso en el tratamiento o la prevencion de una enfermedad asociada a una alteracion de la respuesta inmunitaria | |
| UA97076C2 (ru) | Мазь противовоспалительная на основе сульфаниламида |